Cardlytics (CDLX)
(Delayed Data from NSDQ)
$3.31 USD
-0.12 (-3.50%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $3.31 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Cardlytics (CDLX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$7.50 | $12.00 | $3.50 | 118.66% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Cardlytics comes to $7.50. The forecasts range from a low of $3.50 to a high of $12.00. The average price target represents an increase of 118.66% from the last closing price of $3.43.
Analyst Price Targets (5 )
Broker Rating
Cardlytics currently has an average brokerage recommendation (ABR) of 3.20 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 2.60 a month ago based on five recommendations.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 1 | 3 | 2 |
Buy | 0 | 0 | 0 | 1 | 1 |
Hold | 4 | 4 | 4 | 1 | 0 |
Sell | 1 | 1 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 3.20 | 3.20 | 2.60 | 1.60 | 1.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/16/2024 | Northland Capital Markets | Luke Horton | Strong Buy | Hold |
8/8/2024 | Needham & Company | Kyle Peterson | Moderate Buy | Hold |
8/8/2024 | Lake Street Capital Markets | Jacob M Stephan | Strong Buy | Hold |
8/8/2024 | Craig-Hallum | Jason Kreyer | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.20 |
ABR (Last week) | 3.20 |
# of Recs in ABR | 5 |
Average Target Price | $7.50 |
LT Growth Rate | NA |
Industry | Technology Services |
Industry Rank by ABR | 82 of 253 |
Current Quarter EPS Est: | -0.33 |
CDLX FAQs
Cardlytics, Inc. (CDLX) currently has an average brokerage recommendation (ABR) of 3.20 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for Cardlytics, Inc. (CDLX) is $7.50. The current on short-term price targets is based on 1 reports.
The forecasts for Cardlytics, Inc. (CDLX) range from a low of $3.5 to a high of $12. The average price target represents a increase of $118.66 from the last closing price of $3.43.
The current UPSIDE for Cardlytics, Inc. (CDLX) is 118.66%
Based on short-term price targets offered by five analysts, the average price target for Cardlytics comes to $7.50. The forecasts range from a low of $3.50 to a high of $12.00. The average price target represents an increase of 118.66% from the last closing price of $3.43.